Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing

International Journal of Obesity

Volumn 39, Issue 12, 2015, Pages 1717-1720

  Hamer, M ^a   Batty, G D ^a   Kivimaki, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BODY WEIGHT; CLINICAL STUDY; COHORT ANALYSIS; DEPRESSION; DYNAMOMETRY; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RISK FACTOR; SARCOPENIC OBESITY; COMPLICATION; ENGLAND; HAND STRENGTH; MUSCLE STRENGTH; OBESITY; ODDS RATIO; PATHOPHYSIOLOGY; PSYCHOLOGY; SARCOPENIA; SEX DIFFERENCE;

AGED; AGING; DEPRESSION; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HAND STRENGTH; HUMANS; LONGITUDINAL STUDIES; MALE; MUSCLE STRENGTH; OBESITY; ODDS RATIO; RISK FACTORS; SARCOPENIA; SEX FACTORS;

EID: 84949624554     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.124     Document Type: Article

References (32)

1. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW. Overweight, obesity, and depression: a systematic review and meta-Analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229
2. Istvan J, Zavela K, Weidner G. Bodyweight and psychological distress in NHANES I. Int J Obes Relat Metab Disord 1992; 16: 999-1003
3. Crisp AH, McGuiness B. Jolly fat: relation between obesity and psychoneurosis in general population. BMJ 1976; 1: 7-9
4. Magnusson PK, Rasmussen F, Lawlor DA, Tynelius P, Gunnell D. Association of body mass index with suicide mortality: a prospective cohort study of more than one million men. Am J Epidemiol 2006; 163: 1-8
5. Kivimäki M, Jokela M, Hamer M, Geddes J, Ebmeier K, Kumari M et al. Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesity-Associated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985-2004. Am J Epidemiol 2011; 173: 421-429
6. Lawlor DA, Harbord R, Tybaerg-Hansen A. Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population study of 53, 221 adults. J Intern Med 2011; 269: 525-537
7. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-Analysis. Ann Intern Med 2013; 159: 758-769
8. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010; 33: 1652-1654
9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423
10. Sayer AA, Syddall HE, Dennison EM, Martin HJ, Phillips DI, Cooper C et al. Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM 2007; 100: 707-713
11. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesityassociated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 2010; 5: e10805
12. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011; 96: 2898-2903
13. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102: 919-925
14. Visser M, van Venrooij LM, Vulperhorst L, de Vos R, Wisselink W, van Leeuwen PA et al. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis 2013; 23: 511-518
15. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 2013; 56: 270-278
16. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a populationbased cohort study of older men. J Am Geriatr Soc 2014; 62: 253-260
17. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 2014; 68: 1001-1007
18. Hsu YH, Liang CK, Chou MY, Liao MC, Lin YT, Chen LK et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a crosssectional study. Geriatr Gerontol Int 2014; 14: 102-108
19. Kim NH, Kim HS, Eun CR, Seo JA, Cho HJ, Kim SG et al. Depression is associated with sarcopenia, not central obesity, in elderly korean men. J Am Geriatr Soc 2011; 59: 2062-2068
20. Steptoe A, Breeze E, Banks J, Nazroo J. Chort Profile: The English Longitudinal Study of Ageing. Int J Epidemiol 2013; 42: 1640-1648
21. Banks JA, Karlsen S, Oldfield Z. Socio-economic position. In: Marmot M, Banks JA, Blundell R, Lessof C, Nazroo J (Eds). Health, Wealth and Lifestyles of the Older Population in England: The 2002 English Longitudinal Study of Ageing. Institute of Fiscal Studies: London, 2003
22. Hamer M, Batty GD, Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol Psychiatry 2012; 17: 940-945
23. Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 1999; 159: 1701-1704
24. Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED. Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med 1997; 157: 449-454
25. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547-558
26. Jokela M, Hamer M, Singh-Manoux A, Batty GD, Kivimäki M. Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Mol Psychiatry 2014; 19: 910-914
27. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009; 32: S157-S163
28. Akbaraly TN, Kumari M, Head J, Ritchie K, Ancelin ML, Tabák AG et al. Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age. Diabetes Care 2013; 36: 928-934
29. Adriaanse MC, Dekker JM, Nijpels G, Heine RJ, Snoek FJ, Pouwer F. Associations between depressive symptoms and insulin resistance: the Hoorn Study. Diabetologia 2006; 49: 2874-2877
30. Gale CR, Kivimaki M, Lawlor DA, Carroll D, Phillips AC, Batty GD. Fasting glucose, diagnosis of type 2 diabetes, and depression: the Vietnam experience study. Biol Psychiatry 2010; 67: 189-192
31. Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010; 53: 2298-2306
32. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059-1064